Beroni Group Ltd BNIGF
The SEC does not publish structured financial data (XBRL) for Beroni Group Ltd, so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF ACTION | Filing | Jun 13, 2025 | — |
| F-1/A | Filing | Feb 14, 2024 | — |
| F-1/A | Filing | Jan 24, 2024 | — |
| F-1/A | Filing | Dec 14, 2023 | — |
| F-1/A | Filing | Nov 7, 2023 | — |
| F-1/A | Filing | Aug 21, 2023 | — |
| F-1/A | Filing | Feb 2, 2023 | — |
| F-1/A | Filing | Dec 23, 2022 | — |
| F-1/A | Filing | Jun 9, 2022 | — |
| F-1/A | Filing | May 24, 2022 | — |
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BNIGF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Australia
- Headquarters
- Sydney, Australia
- SEC CIK
- 1851651
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.